>

>

What can portfolio management do for early commercialization?

Therapeutic Areas

N/A

Client Type

Client Problems

  • Commercial Heads need to develop specific disease area strategies and seek Governance approval


  • Teams need guidance on governance-approved TA priorities (e.g., TPP hurdles; prioritized indications and/or MOAs, development plans, diagnostic strategies)

What We Did

  • Provide strategic support and analytical horsepower to TA Heads and cross-functional disease area strategy teams


  • Provide consistent support across TA’s and share best practices (e.g., TPP consistency; analytical tools; guidance for governance)

Our Results And Insight

  • Framework for disease area strategy


  • Consistent TPP approach, including market research


  • Evaluate scenarios and analyze sensitivity to key assumptions
case_study_image_placeholder.png
case_study_image_placeholder.png
case_study_image_placeholder.png

See other case studies

Portfolio Management case studies >

Service Areas Details

Portfolio Management (Early Commercialization)

Therapeutic Areas Details

N/A

Featured Consultants